艾美捷科技代理Larova GmbH超纯脱氧核糖核苷酸（dNTPs）。

Larova GmbH位于德国，主要生产超纯脱氧核糖核苷酸（dNTPs）及预混的dNTPs。Larova可根据需求提供定制dNTP浓度及反离子的溶液，dNTP溶液提供从50 mL到1000 L的量级，包装规格为0.25 mL至200 mL。Larova也可以提供预混dNTPs，预混的超纯脱氧核糖核苷酸（dNTPs）溶液，便于在PCR应用中使用。标准预混液包含等摩尔浓度的dATP、dCTP、dGTP和dTTP，也可根据需求提供不同浓度或包含dUTP的定制预混液。产品特点包括：（1）超纯（>99.0%纯度）、（2）稳定性、（3）不含人类和大肠杆菌DNA、（4）不含DNase、RNase和蛋白酶。主要应用于长片段PCR、cDNA合成和RT-PCR、实时荧光定量PCR、标准PCR、高保真PCR。

Chem Service公司成立于1962年，专注于制造高品质、高纯度的标准物质。

Established in 1962, Chem Service is accredited to ISO Guide 34:2009, ISO/IEC 17025:2005, and registered and certified to the ISO 9001:2008 Quality Management System for the design, development, production, distribution, and servicing of organic neat and synthetic reference materials.

Chem Service, Inc. produces high purity standards for use as reference materials and for other laboratory purposes. More than 95% of our Standards Grade materials have a certified purity of 98.0% or greater and do not require purity corrections when preparing solutions for use with EPA, USTM, UST, and numerous other international methods. You can trust that our high purity standards are a quality product.

Standards Grade chemicals are clearly labeled with an expiration date that is based on years of experience in handling and testing. Products are packaged in small quantities to minimize storage, waste, and disposal requirements. Organic and inorganic chemicals, solutions, and mixtures are available to meet a wide range of specialized laboratory needs.

艾美捷科技特约代理Avidity Biosciences公司产品。

Avidity Biosciences公司位于美国加州La Jolla，是一家专门从事抗体寡核苷酸结合物（AOC™）技术开发的生物技术公司，此项技术结合了单抗组织选择性和寡核苷酸疗法的精确性，克服了寡核苷酸给药屏障。

Avidity Biosciences is a privately-held biotech company pioneering Antibody Oligonucleotide Conjugates (AOC™). AOCs combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapeutics to overcome barriers to the delivery of oligonucleotides and target genetic drivers of disease.

Antibody oligonucleotide conjugate (AOC™) technology

Avidity’s antibody oligonucleotide conjugate (AOC™) technology utilizes antibodies to target cells and tissues of interest and facilitate the uptake and internalization of oligonucleotide payloads. By combining the cellular and tissue selectivity of antibodies with the selectivity and efficiency of oligo-based approaches, Avidity has demonstrated modulation of disease-related RNAs in diverse cell types and tissues including muscle, heart, liver, tumors and immune cells.